Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Izotropic Corp. C.IZO

Alternate Symbol(s):  IZOZF

Izotropic Corp is a Canada based company. It is engaged in the development and commercialization of the Izotropic Breast Imaging System for application in proprietary diagnostic products for breast cancer.

Recent & Breaking News (CSE:IZO)

Izotropic Receives Response From U.S. FDA

Newsfile January 30, 2024

Izotropic Provides Regulatory and Operational Updates

TheNewsWire January 8, 2024

Izotropic Announces AGM Results

TheNewsWire December 22, 2023

Izotropic Completes Pre-Submission Meeting with U.S. FDA

Newsfile November 1, 2023

Izotropic Confirms FDA Pre-Submission Meeting Date

TheNewsWire September 27, 2023

Izotropic Closes Non-Brokered Private Placement

TheNewsWire September 20, 2023

Izotropic Corporation Announces Non-Brokered Private Placement

TheNewsWire September 13, 2023

Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices

Newsfile September 6, 2023

Izotropic Engages Market Awareness Consultant

TheNewsWire June 27, 2023

Izotropic Modifies Market Approval Pathway & Strategy

TheNewsWire June 20, 2023

Izotropic CEO Resigns

TheNewsWire June 8, 2023

Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration

TheNewsWire May 15, 2023

Izotropic Provides Business Update

TheNewsWire April 27, 2023

Izotropic to Extend Period for Unsecured Loans

TheNewsWire March 29, 2023

Izotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology

Newsfile February 23, 2023

Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA

TheNewsWire January 13, 2023

Izotropic Creates Compensation Committee and Adopts Charter

TheNewsWire January 12, 2023

Izotropic (CSE:IZO) releases IzoView video

John Ballem  January 9, 2023

Izotropic Releases First Video of Izoview

TheNewsWire January 9, 2023

Izotropic Reports Board Meeting Results

Newsfile January 4, 2023